Skip to content

Audition After a Lesion and in Migraine. (AuditionPostLesion)

Consequences of a Brain Lesion or of Migraine on Auditory Processing: Attention, Memory and Emotion

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02791997
Enrollment
262
Registered
2016-06-07
Start date
2015-02-06
Completion date
2020-09-09
Last updated
2025-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine Disorders, Brain

Keywords

Audition, Stroke, Migraine, Attention, Short-term memory,, Emotions, EEG, MEG

Brief summary

The project studies auditory processing after brain damage (in temporal and/or frontal areas) and in migraine. The auditory processes investigated are attention, short-term memory, sound-induced emotions. To characterize auditory deficits after brain damage or in migraine, neuropsychological assessments are combined with neurophysiological markers (Electro-encephalography: EEG, Magneto-encephalography: MEG, Magnetic Resonance Imaging: MRI).

Interventions

OTHERNeuropsychological tests

Neuropsychological tests consist in listening to sounds in various contexts and providing behavioral responses with response-buttons.

OTHERNeurophysiological tests

Neurophysiological tests consist in the recording of EEG and/or MEG signals while realizing the neuropsychological tests, as well as MRI scanning to characterize the patients' brain lesions and reconstruct the brain sources of surface EEG/MEG signals.

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Age from 18 to 80 * MEG/MRI compatibility * Motivation to participate efficiently in the study * No severe hearing loss * Informed consent to participate in the study * Affiliation to social security * For brain-damaged patients : no need for medical assistance; focal temporal and/or frontal lesion; no major cognitive impairment; ability to understand and apply the instructions for neuropsychological testing; testing at least one-month after the event resulting in brain damage; absence of neurological and psychiatric disorders besides the lesion * For migraine patients: no need for medical assistance; migraine diagnosis; no major cognitive impairment; ability to understand and apply the instructions for neuropsychological testing; absence of neurological and psychiatric disorders besides the migraine * Healthy participants: absence of neurological and psychiatric disorders

Exclusion criteria

* Age below 18 or above 80 * MRI scanning not possible: artificial cardiac pacemaker, insulin pump, metallic prosthesis, intra-cerebral clip, claustrophobia * MEG acquisition not possible: large heads, neurostimulator, metal in the head or the body. * Pregnant or breast-feeding women

Design outcomes

Primary

MeasureTime frame
Percentages of correct responses in Neuropsychological testsup to 2 months
reaction times in Neuropsychological testsup to 2 months

Secondary

MeasureTime frame
Event-Related Potentials (EEG) in Neurophysiological testsup to 2 months
Event-Related Fields (MEG) in Neurophysiological testsup to 2 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026